Spinal injection cut death risk by 55% in severe Niemann-Pick C
The FDA approved Lembaz (adrabetadex) on 17 November 2026 for infantile-onset Niemann-Pick C, after 36 treated patients had a 55% lower risk of death than matched untreated controls.
17 November 2026